Works matching DE "VASCULAR endothelial growth factor antagonists"
Results: 1604
Updates on the Management of Breast Cancer Brain Metastases.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 572
- By:
- Publication type:
- Article
Colorectal Cancer: How Emerging Molecular Understanding Affects Treatment Decisions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 110
- By:
- Publication type:
- Article
Weighing the Evidence for Immune Therapy and Targeted Therapy in Renal Cancer and Melanoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 691
- By:
- Publication type:
- Article
High-Dose Interleukin-2: Is It Still Indicated for Melanoma and RCC in an Era of Targeted Therapies?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 680
- By:
- Publication type:
- Article
Renal Cancer Therapeutics: Now What?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 3, p. 301
- By:
- Publication type:
- Article
Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 3, p. 290
- By:
- Publication type:
- Article
PHASE 3 TRIAL TO EXPLORE RCC COMBINATION.
- Published in:
- Urology Times, 2021, v. 49, n. 4, p. 34
- By:
- Publication type:
- Article
Phase III RCC trial challenges current standard of care: Sunitinib found non-inferior to nephrectomy plus targeted therapy.
- Published in:
- Urology Times, 2018, v. 46, n. 10, p. 22
- By:
- Publication type:
- Article
Novel VEGF inhibitor may play role in advanced RCC.
- Published in:
- Urology Times, 2013, v. 41, n. 5, p. 14
- By:
- Publication type:
- Article
Titration of RCC Tx may be needed for optimum efficacy.
- Published in:
- Urology Times, 2012, v. 40, n. 6, p. 30
- By:
- Publication type:
- Article
Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy.
- Published in:
- Documenta Ophthalmologica, 2022, v. 145, n. 3, p. 211, doi. 10.1007/s10633-022-09895-7
- By:
- Publication type:
- Article
Five-year outcomes of treat and extend regimen using intravitreal aflibercept injection for treatment-naïve age-related macular degeneration.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 11, p. 3483, doi. 10.1007/s00417-024-06519-5
- By:
- Publication type:
- Article
Response to letter to the editor Re: comment on "Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration".
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 11, p. 3735, doi. 10.1007/s00417-024-06516-8
- By:
- Publication type:
- Article
Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 10, p. 3191, doi. 10.1007/s00417-024-06499-6
- By:
- Publication type:
- Article
Subthreshold micropulse laser combined with anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 10, p. 3073, doi. 10.1007/s00417-024-06460-7
- By:
- Publication type:
- Article
Treatment of myopic choroidal neovascularization: a network meta-analysis and review.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 6, p. 1693, doi. 10.1007/s00417-023-06271-2
- By:
- Publication type:
- Article
Long-term predictors of anti-VEGF treatment response in patients with neovascularization secondary to CSCR: a longitudinal study.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 1, p. 73, doi. 10.1007/s00417-023-06255-2
- By:
- Publication type:
- Article
Long-term efficacy and complications of intravitreal anti-vascular endothelial growth factor agents combined with ablative therapies in juvenile Coats disease: a five year follow-up study.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 1, p. 305, doi. 10.1007/s00417-023-06162-6
- By:
- Publication type:
- Article
Correction to: Persistence of vascular empty sleeves in choroidal neovascularization after anti-VEGF therapy in both animal models and humans.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 4, p. 941, doi. 10.1007/s00417-022-05892-3
- By:
- Publication type:
- Article
Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 2, p. 345, doi. 10.1007/s00417-022-05793-5
- By:
- Publication type:
- Article
Two-year outcomes of episcleral brachytherapy adjunct to anti-VEGF therapy for treatment-resistant nAMD.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 12, p. 3791, doi. 10.1007/s00417-022-05736-0
- By:
- Publication type:
- Article
Sub-Tenon's capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 8, p. 2529, doi. 10.1007/s00417-022-05611-y
- By:
- Publication type:
- Article
The detrimental effects of delayed intravitreal anti-VEGF therapy for treating retinal pathology: lessons from a forced test-case.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 7, p. 2201, doi. 10.1007/s00417-021-05549-7
- By:
- Publication type:
- Article
Comparison of agents using higher dose anti-VEGF therapy for treatment-resistant neovascular age-related macular degeneration.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 7, p. 2239, doi. 10.1007/s00417-021-05547-9
- By:
- Publication type:
- Article
A 10-point score classification for anti-VEGF response in exudative AMD.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 6, p. 2073, doi. 10.1007/s00417-021-05478-5
- By:
- Publication type:
- Article
Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 4, p. 1083, doi. 10.1007/s00417-021-05359-x
- By:
- Publication type:
- Article
Anti-VEGF therapies for age-related macular degeneration: a powerful tactical gear or a blunt weapon? The choice is ours.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3561, doi. 10.1007/s00417-021-05451-2
- By:
- Publication type:
- Article
Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3649, doi. 10.1007/s00417-021-05324-8
- By:
- Publication type:
- Article
Intravitreal air bubbles following intravitreal injections: a comprehensive analysis.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3697, doi. 10.1007/s00417-021-05302-0
- By:
- Publication type:
- Article
Results of patients with neovascular age-related macular degeneration managed by a treat-extend-stop protocol without recurrence.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3665, doi. 10.1007/s00417-021-05283-0
- By:
- Publication type:
- Article
Seasonal variation in submacular hemorrhages in retinal macroaneurysms and its disappearance in age-related macular degeneration.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3589, doi. 10.1007/s00417-021-05280-3
- By:
- Publication type:
- Article
Differences in the characteristics of subjects achieving complete, partial, or no resolution of macular edema in the READ-3 study.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 10, p. 2941, doi. 10.1007/s00417-021-05148-6
- By:
- Publication type:
- Article
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 9, p. 2653, doi. 10.1007/s00417-021-05146-8
- By:
- Publication type:
- Article
Choroidal neovascularization secondary to pathological myopia—macular Bruch membrane defects as prognostic factor to anti-VEGF treatment.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 9, p. 2679, doi. 10.1007/s00417-021-05142-y
- By:
- Publication type:
- Article
Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 8, p. 2085, doi. 10.1007/s00417-020-05059-y
- By:
- Publication type:
- Article
Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 8, p. 2181, doi. 10.1007/s00417-020-05048-1
- By:
- Publication type:
- Article
Comparative analysis of polypoidal choroidal vasculopathy with and without hemorrhage treated by anti-VEGF monotherapy.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 7, p. 1741, doi. 10.1007/s00417-020-05033-8
- By:
- Publication type:
- Article
Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents: SCORE2 report 12: secondary analysis of the SCORE2 clinical trial.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 7, p. 1839, doi. 10.1007/s00417-020-05018-7
- By:
- Publication type:
- Article
Inhibition of retinal neovascularization by VEGF siRNA delivered via bioreducible lipid-like nanoparticles.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2020, v. 258, n. 11, p. 2407, doi. 10.1007/s00417-020-04797-3
- By:
- Publication type:
- Article
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2020, v. 258, n. 6, p. 1149, doi. 10.1007/s00417-020-04703-x
- By:
- Publication type:
- Article
A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 8, p. 1073, doi. 10.1007/s00228-023-03513-4
- By:
- Publication type:
- Article
Lenvatinib in the treatment of unresectable hepatocellular carcinoma: a systematic review of economic evaluations.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 885, doi. 10.1007/s00228-023-03502-7
- By:
- Publication type:
- Article
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 505, doi. 10.1007/s00228-011-1173-6
- By:
- Publication type:
- Article
Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 645, doi. 10.1007/s00228-011-1171-8
- By:
- Publication type:
- Article
Molecular-targeted therapy for childhood low-grade glial and glioneuronal tumors.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 10, p. 3251, doi. 10.1007/s00381-024-06486-6
- By:
- Publication type:
- Article
Biologically inhibitory effects of VEGF siRNA on endometrial carcinoma cells.
- Published in:
- Archives of Gynecology & Obstetrics, 2011, v. 284, n. 6, p. 1533, doi. 10.1007/s00404-011-1891-0
- By:
- Publication type:
- Article
Biosimilars in Ophthalmology: Financial Implications and Beyond.
- Published in:
- touchREVIEWS in Ophthalmology, 2022, v. 16, n. 2, p. 98, doi. 10.17925/USOR.2022.16.2.98
- By:
- Publication type:
- Article
Faricimab in the Treatment Landscape for Retinal Diseases: A Review.
- Published in:
- touchREVIEWS in Ophthalmology, 2022, v. 16, n. 2, p. 92, doi. 10.17925/USOR.2022.16.2.92
- By:
- Publication type:
- Article
Xerosis as the toxicity of novel anti-cancer therapies — pathophysiology and management.
- Published in:
- Forum Dermatologicum, 2023, v. 9, n. 2, p. 50, doi. 10.5603/FD.a2023.0004
- By:
- Publication type:
- Article